3 Stocks Under $10 With Over 100% Upside, According to Analysts
Some low‑priced stocks are drawing attention from Wall Street thanks to their growth plans and strong sector trends. These names trade under $10 bu...
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 5,063,516 | $6,073,333,633 | +5% | 1.81% |
| 2. | 2,349,200 | $2,817,700,956 | +49% | 0.32% | |
| 3. | 1,881,500 | $2,256,727,545 | +10% | 0.26% | |
| 4. | AQR Capital Management Cliff Asness | 1,035,605 | $1,242,135,647 | +22% | 0.43% |
| 5. | Citadel Investment Group Ken Griffin | 945,456 | $1,134,008,290 | +292% | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $691.79 | 715 | $494,626.99 | 14,685 | 2025-08-15 | Filing | |
| $660.25 | 758 | $500,472.53 | 758 | 2025-08-13 | Filing | |
| $647.36 | 1,000 | $647,360.00 | 20,562 | 2025-08-13 | Filing | |
| $644.77 | 1,632 | $1,052,263.01 | 546,601 | 2025-08-12 | Filing | |
| $634.41 | 1,000 | $634,405.00 | 137,660 | 2025-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1,175.10 | 6,500 | $7,638,150.00 | 54,147 | 2026-08-17 | Filing | |
| $1,185.01 | 2,000 | $2,370,020.00 | 1,526 | 2026-08-10 | Filing | |
| $1,190.00 | 5,000 | $5,950,000.00 | 11,875 | 2026-08-07 | Filing | |
| $1,150.77 | 2,500 | $2,876,925.00 | 29,804 | 2026-06-10 | Filing | |
| $996.18 | 2,208 | $2,199,572.06 | 91,881,150 | 2026-05-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 90,376,978 | $108,400,858,723 | 100% | |
| 2. | 67,540,400 | $81,009,980,560 | 1.2% | |
| 3. | 53,528,868 | $64,204,130,146 | 1.37% | |
| 4. | 51,304,828 | $61,536,549,849 | 30.5% | |
| 5. | 36,215,754 | $43,438,261,820 | 1.29% |
News See All
Markets at Midday: Rally Accelerates with Dow Up Nearly 500 Points
U.S. equities are on pace for a weekly loss.
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK
Drugmaker Bristol-Myers Squibb Company (NYSE:BMY) is putting real money behind its confidence in American manufacturing.
Eli Lilly Stock (LLY) Hits All-Time High as Post-Earnings Rally Continues
The drug maker is seeing accelerating sales of its weight-loss medications.
Can Eli Lilly Catch Novo Nordisk in the Oral GLP-1 Race?
The battle between Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) has so far been defined by blockbuster injectable weight loss drugs. But the next phase of that rivalry may look very different.
UnitedHealth Group (UNH) vs. Eli Lilly and Company (LLY): Which Healthcare Stock Offers the Better Dividend?
UnitedHealth Group Incorporated (NYSE:UNH) and Eli Lilly and Company (NYSE:LLY) both have respectable dividend records, but the two companies are at different stages of their dividend journeys.
Eli Lilly and Company (LLY)'s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start
On August 10, Eli Lilly and Company (NYSE:LLY)'s weight-loss pill Foundayo won approval in the UK, becoming the first country in Europe to clear the drug for both weight management and type 2 diabetes...
Eli Lilly's (LLY) Growth Story Keeps Adding Chapters
On August 5, Eli Lilly (NYSE:LLY) told investors its second quarter delivered 48% revenue growth, and the days since have brought even more good news.
Eli Lilly's Weight-Loss Pill Just Got Its First Foothold in Europe
Eli Lilly and Company (NYSE:LLY) cleared a notable regulatory hurdle on August 10, when Britain's drug regulator authorized the company's oral GLP-1 drug orforglipron, becoming the first country in Europe...
Can Veeva Systems Inc. (VEEV)’s AI Platform Keep Pace With Eli Lilly and Company (LLY)’s Explosive Growth
On August 11, Veeva Systems Inc. (NYSE:VEEV) announced that Eli Lilly and Company (NYSE:LLY) committed to deploying Veeva Vault CRM globally.
Hedge Fund Resource Center